Forum - How artificial intelligence can change the pharmaceutical landscape


Institutional Communication Service

Date: 9 October 2019 / 13:30 - 17:45

LAC Lugano Arte e Cultura

Artificial Intelligence (AI) is gaining more and more importance in the pharmaceutical sector, deeply transforming the drug discovery process. There are many potential benefits of applying AI techniques to improve the development of new molecules and the identification of new targets, cutting R&D costs and time. In drug discovery, AI helps in predicting the efficacy and safety of molecules. It gives researchers a much broader chemical pallet for the selection of the best molecules for drug testing and delivery. In this context, drug repurposing is another important area where AI can have a substantial impact. With the extensive amount of clinical and pharmaceutical data available to date, AI algorithms find suitable drugs that can be repurposed for an alternative use in medicine. Moreover, with the help of AI, it becomes easier to run clinical tests, diagnose diseases and provide the most effective treatment for a particular disease. As it can interpret test results, AI can also look through various sources including publications to correctly diagnose critical ailments. New approaches based on AI in the drug discovery process and in the repositioning of old molecules will be presented during this particular Forum. We hope to provide an overview of the sectors where AI might have an impact on the pharmaceutical pipeline and play a crucial role in the pharmaceutical world in the coming years.

The Forum is organized by IBSA Foundation for Scientific Research in collaboration with Andrea Danani (Dalle Molle Institute for Artificial Intelligence Studies, IDSIA USI-SUPSI),

Free admission, subject to mandatory registration at the IBSA Foundation website


>>> followed by the event CONVIVIUM "FUTURO+UMANO"